Literature DB >> 28701354

Pleiotropic effects of apolipoprotein C3 on HDL functionality and adipose tissue metabolic activity.

Evangelia Zvintzou1, Marie Lhomme2, Stella Chasapi3, Serafoula Filou1, Vassilis Theodoropoulos1, Eva Xapapadaki1, Anatol Kontush4, George Spyroulias3, Constantinos C Tellis5, Alexandros D Tselepis5, Caterina Constantinou1, Kyriakos E Kypreos6.   

Abstract

APOC3 is produced mainly by the liver and intestine and approximately half of plasma APOC3 associates with HDL. Though it was believed that APOC3 associates with HDL by simple binding to preexisting particles, recent data support that biogenesis of APOC3-containing HDL (APOC3-HDL) requires Abca1. Moreover, APOC3-HDL contributes to plasma triglyceride homeostasis by preventing APOC3 association with triglyceride-rich lipoproteins. Interestingly, APOC3-HDL also shows positive correlation with the morbidly obese phenotype. However, the roles of APOC3 in HDL functionality and adipose tissue metabolic activity remain unknown. Therefore, here we investigated the direct effects of APOC3 expression on HDL structure and function, as well as white adipose tissue (WAT) and brown adipose tissue (BAT) metabolic activity. C57BL/6 mice were infected with an adenovirus expressing human APOC3 or a recombinant attenuated control adenovirus expressing green fluorescent protein and blood and tissue samples were collected at 5 days postinfection. HDL was then analyzed for its apolipoprotein and lipid composition and particle functionality. Additionally, purified mitochondria from BAT and WAT were analyzed for uncoupling protein 1, cytochrome c (Cytc), and Cytc oxidase subunit 4 protein levels as an indirect measure of their metabolic activity. Serum metabolomic analysis was performed by NMR. Combined, our data show that APOC3 modulates HDL structure and function, while it selectively promotes BAT metabolic activation.
Copyright © 2017 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  brown adipose tissue; cholesterol efflux; high density lipoprotein; lipidomics; metabolomics; white adipose tissue

Mesh:

Substances:

Year:  2017        PMID: 28701354      PMCID: PMC5580900          DOI: 10.1194/jlr.M077925

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  64 in total

1.  Proteomic analysis of high-density lipoprotein.

Authors:  Farhad Rezaee; Bruno Casetta; J Han M Levels; Dave Speijer; Joost C M Meijers
Journal:  Proteomics       Date:  2006-01       Impact factor: 3.984

2.  Apolipoprotein specificity for lipid efflux by the human ABCAI transporter.

Authors:  A T Remaley; J A Stonik; S J Demosky; E B Neufeld; A V Bocharov; T G Vishnyakova; T L Eggerman; A P Patterson; N J Duverger; S Santamarina-Fojo; H B Brewer
Journal:  Biochem Biophys Res Commun       Date:  2001-01-26       Impact factor: 3.575

3.  Isolation and alignment of the tryptic peptides of alanine apolipoprotein, an apolipoprotein from human plasma very low density lipoproteins.

Authors:  R S Shulman; P N Herbert; D S Fredrickson; K Wehrly; H B Brewer
Journal:  J Biol Chem       Date:  1974-08-10       Impact factor: 5.157

4.  PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme.

Authors:  A D Tselepis; C Dentan; S A Karabina; M J Chapman; E Ninio
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-10       Impact factor: 8.311

Review 5.  Thermogenic mechanisms in brown fat.

Authors:  D G Nicholls; R M Locke
Journal:  Physiol Rev       Date:  1984-01       Impact factor: 37.312

6.  Effect of apoproteins on hepatic uptake of triglyceride emulsions in the rat.

Authors:  F Shelburne; J Hanks; W Meyers; S Quarfordt
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

7.  Effects of bariatric surgery on HDL structure and functionality: results from a prospective trial.

Authors:  Evangelia Zvintzou; George Skroubis; Angelika Chroni; Peristera-Ioanna Petropoulou; Christina Gkolfinopoulou; George Sakellaropoulos; Donald Gantz; Ioanna Mihou; Fotios Kalfarentzos; Kyriakos E Kypreos
Journal:  J Clin Lipidol       Date:  2014-05-21       Impact factor: 4.766

8.  Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.

Authors:  Altan Onat; Gülay Hergenç; Vedat Sansoy; Manfred Fobker; Köksal Ceyhan; Sadik Toprak; Gerd Assmann
Journal:  Atherosclerosis       Date:  2003-05       Impact factor: 5.162

9.  The estradiol-stimulated lipoprotein receptor of rat liver. A binding site that membrane mediates the uptake of rat lipoproteins containing apoproteins B and E.

Authors:  E E Windler; P T Kovanen; Y S Chao; M S Brown; R J Havel; J L Goldstein
Journal:  J Biol Chem       Date:  1980-11-10       Impact factor: 5.157

10.  ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia.

Authors:  Kyriakos E Kypreos
Journal:  Biochemistry       Date:  2008-09-04       Impact factor: 3.162

View more
  14 in total

1.  Simultaneous LC/MS/MS quantification of eight apolipoproteins in normal and hypercholesterolemic mouse plasma.

Authors:  Richard Wagner; Julia Dittrich; Joachim Thiery; Uta Ceglarek; Ralph Burkhardt
Journal:  J Lipid Res       Date:  2019-02-05       Impact factor: 5.922

2.  High Density Lipoproteins: Is There a Comeback as a Therapeutic Target?

Authors:  Arnold von Eckardstein
Journal:  Handb Exp Pharmacol       Date:  2022

Review 3.  Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics.

Authors:  Yajun Duan; Ke Gong; Suowen Xu; Feng Zhang; Xianshe Meng; Jihong Han
Journal:  Signal Transduct Target Ther       Date:  2022-08-02

Review 4.  ANGPTL3 and Apolipoprotein C-III as Novel Lipid-Lowering Targets.

Authors:  Ioannis Akoumianakis; Evangelia Zvintzou; Kyriakos Kypreos; Theodosios D Filippatos
Journal:  Curr Atheroscler Rep       Date:  2021-03-10       Impact factor: 5.113

Review 5.  Interaction between adipocytes and high-density lipoprotein:new insights into the mechanism of obesity-induced dyslipidemia and atherosclerosis.

Authors:  Tianhua Zhang; Jin Chen; Xiaoyu Tang; Qin Luo; Danyan Xu; Bilian Yu
Journal:  Lipids Health Dis       Date:  2019-12-16       Impact factor: 3.876

Review 6.  The Lipoprotein Transport System in the Pathogenesis of Multiple Myeloma: Advances and Challenges.

Authors:  Vasileios Lazaris; Aikaterini Hatziri; Argiris Symeonidis; Kyriakos E Kypreos
Journal:  Front Oncol       Date:  2021-03-26       Impact factor: 6.244

7.  Lowering apolipoprotein CIII protects against high-fat diet-induced metabolic derangements.

Authors:  Ismael Valladolid-Acebes; Karin Åvall; Patricia Recio-López; Noah Moruzzi; Galyna Bryzgalova; Marie Björnholm; Anna Krook; Elena Fauste Alonso; Madelene Ericsson; Fredrik Landfors; Stefan K Nilsson; Per-Olof Berggren; Lisa Juntti-Berggren
Journal:  Sci Adv       Date:  2021-03-12       Impact factor: 14.136

Review 8.  HDL and type 2 diabetes: the chicken or the egg?

Authors:  Eva Xepapadaki; Ioanna Nikdima; Eleftheria C Sagiadinou; Evangelia Zvintzou; Kyriakos E Kypreos
Journal:  Diabetologia       Date:  2021-07-13       Impact factor: 10.122

9.  HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research.

Authors:  Anand Rohatgi; Marit Westerterp; Arnold von Eckardstein; Alan Remaley; Kerry-Anne Rye
Journal:  Circulation       Date:  2021-06-07       Impact factor: 39.918

10.  Deficiency in interleukin-18 promotes differentiation of brown adipose tissue resulting in fat accumulation despite dyslipidemia.

Authors:  Kyosuke Yamanishi; Seishi Maeda; Sachi Kuwahara-Otani; Takuya Hashimoto; Kaoru Ikubo; Keiichiro Mukai; Keiji Nakasho; Naomi Gamachi; Yosif El-Darawish; Wen Li; Daisuke Okuzaki; Yuko Watanabe; Hiromichi Yamanishi; Haruki Okamura; Hisato Matsunaga
Journal:  J Transl Med       Date:  2018-11-19       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.